Application | Comment | Organism |
---|---|---|
drug development | the dysfunction and upregulation of ATP citrate lyase in numerous cancers makes it an attractive target for developing anticancer therapies. ATP citrate lyase inhibition by shRNA knockdown limits cancer cell proliferation and reduces cancer stemness | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-[[(2-hexyl-6-oxo-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-3-yl)oxy]methyl]-5-methylfuran-2-carboxylic acid | 0.01 mM, 95% inhibition. 0.1 mM, 100% inhibition | Homo sapiens | |
4-[[(3,4-dibenzyl-2-oxo-2H-1-benzopyran-7-yl)oxy]methyl]-5-methylfuran-2-carboxylic acid | 0.01 mM, 3% inhibition. 0.1 mM, 64% inhibition | Homo sapiens | |
4-[[(3,4-dibenzyl-6-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]methyl]-5-methylfuran-2-carboxylic acid | 0.01 mM, 32% inhibition. 0.1 mM, 84% inhibition | Homo sapiens | |
4-[[(6-hexyl-2-oxo-4-phenyl-2H-1-benzopyran-7-yl)oxy]methyl]-5-methylfuran-2-carboxylic acid | 0.01 mM, 53% inhibition. 0.1 mM, 92% inhibition | Homo sapiens | |
5-methyl-4-[[(2-oxo-4-phenyl-2H-1-benzopyran-7-yl)oxy]methyl]furan-2-carboxylic acid | 0.01 mM,32% inhibition. 0.1 mM, 84% inhibition | Homo sapiens | |
5-methyl-4-[[(2-oxo-4-phenyl-6-propyl-2H-1-benzopyran-7-yl)oxy]methyl]furan-2-carboxylic acid | 0.01 mM, 97% inhibition. 0.1 mM, 97% inhibition | Homo sapiens | |
5-methyl-4-[[(4-methyl-2-oxo-3-phenyl-2H-1-benzopyran-7-yl)oxy]methyl]furan-2-carboxylic acid | 0.01 mM, 45% inhibition. 0.1 mM, 101% inhibition | Homo sapiens | |
5-methyl-4-[[(4-methyl-6-oxo-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-3-yl)oxy]methyl]furan-2-carboxylic acid | 0.01 mM, 17% inhibition. 0.1 mM, 90% inhibition | Homo sapiens | |
5-[(2,3-dimethylbenzene-1-sulfonyl)amino]-2-methyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 11% inhibition. 0.1 mM, 43% inhibition | Homo sapiens | |
5-[(4-fluoro-2-methylbenzene-1-sulfonyl)amino]-2-methyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 3% inhibition. 0.1 mM, 9% inhibition | Homo sapiens | |
5-[(4-fluorobenzene-1-sulfonyl)amino]-2-phenyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 19% inhibition. 0.1 mM, 70% inhibition | Homo sapiens | |
5-[(4-methyl-3-nitrobenzene-1-sulfonyl)amino]-2-phenyl-1-benzofuran-3-carboxylic acid | 0.01 mM,21% inhibition. 0.1 mM, 89% inhibition | Homo sapiens | |
5-[(4-methylbenzene-1-sulfonyl)amino]-2-phenyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 23% inhibition. 0.1 mM, 93% inhibition | Homo sapiens | |
5-[(benzenesulfonyl)amino]-2-phenyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 11% inhibition. 0.1 mM, 56% inhibition | Homo sapiens | |
5-[[(3,4-dibenzyl-2-oxo-2H-1-benzopyran-7-yl)oxy]methyl]furan-2-carboxylic acid | 0.01 mM, 9% inhibition. 0.1 mM, 49% inhibition | Homo sapiens | |
5-[[(4-methyl-6-oxo-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-3-yl)oxy]methyl]furan-2-carboxylic acid | 0.01 mM, 18% inhibition. 0.1 mM, 88% inhibition | Homo sapiens | |
6,7-dibenzyl-2-methyl-5-[(4-methylbenzene-1-sulfonyl)amino]-1-benzofuran-3-carboxylic acid | 0.01 mM, 12% inhibition. 0.1 mM, 42% inhibition | Homo sapiens | |
6,7-dibenzyl-5-[(4-ethylbenzene-1-sulfonyl)amino]-2-methyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 42% inhibition. 0.1 mM, 97% inhibition | Homo sapiens | |
6,7-dibenzyl-5-[(4-fluorobenzene-1-sulfonyl)amino]-2-methyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 28% inhibition. 0.1 mM, 95% inhibition | Homo sapiens | |
6,7-dibenzyl-5-[(4-tert-butylbenzene-1-sulfonyl)amino]-2-methyl-1-benzofuran-3-carboxylic acid | 0.01 mM, 16% inhibition. 0.1 mM, 59% inhibition | Homo sapiens | |
BMS-303141 | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + citrate + CoA | Homo sapiens | the enzyme catalyzes the formation of cytosolic acetyl CoA, the starting material for de novo lipid and cholesterol biosynthesis | ADP + phosphate + acetyl-CoA + oxaloacetate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P53396 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + citrate + CoA | - |
Homo sapiens | ADP + phosphate + acetyl-CoA + oxaloacetate | - |
? | |
ATP + citrate + CoA | the enzyme catalyzes the formation of cytosolic acetyl CoA, the starting material for de novo lipid and cholesterol biosynthesis | Homo sapiens | ADP + phosphate + acetyl-CoA + oxaloacetate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ACL | - |
Homo sapiens |
ATP citrate lyase | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000377 | - |
pH 8.0, temperature not specified in the publication | Homo sapiens | BMS-303141 | |
0.0041 | - |
pH 8.0, temperature not specified in the publication | Homo sapiens | 5-methyl-4-[[(2-oxo-4-phenyl-6-propyl-2H-1-benzopyran-7-yl)oxy]methyl]furan-2-carboxylic acid | |
0.0119 | - |
pH 8.0, temperature not specified in the publication | Homo sapiens | 5-methyl-4-[[(4-methyl-2-oxo-3-phenyl-2H-1-benzopyran-7-yl)oxy]methyl]furan-2-carboxylic acid | |
0.0138 | - |
pH 8.0, temperature not specified in the publication | Homo sapiens | 6,7-dibenzyl-5-[(4-ethylbenzene-1-sulfonyl)amino]-2-methyl-1-benzofuran-3-carboxylic acid |
General Information | Comment | Organism |
---|---|---|
metabolism | the enzyme catalyzes the formation of cytosolic acetyl CoA, the starting material for de novo lipid and cholesterol biosynthesis | Homo sapiens |